Greyhound, not sure why BTA should get rid of pipeline...

Greyhound, not sure why BTA should get rid of pipeline developments.... I'm sure they will continue to pursue their early licensing model when appropriate...

I assume they threw an extra $25M at getting BTA798 to Phase III because of the pandemic cash, as well as lack of interest (which I find strange as the guys pushing the previous HRV candidate, Plencoril, had no problems licensing out there's back in the day, as well as a number of other big Pharmas having a stab at HRV).

Still, LANI alone is exciting.... Roche generated $10 billion turnover over 10 years on Tamiflu... if we can replicate half of that or more we'll be sitting pretty...